生物学的データの可視化の世界市場

生物学的データの可視化の世界市場は2030年までに21億米ドルに達する

2024年に13億米ドルと推定される生物学的データの可視化の世界市場は、2024年から2030年にかけてCAGR 7.8%で成長し、2030年には21億米ドルに達すると予測されます。本レポートで分析されているセグメントの1つであるシーケンシングは、CAGR 7.9%を記録し、分析期間終了時には8億1,450万米ドルに達すると予測されています。顕微鏡分野の成長率は、分析期間でCAGR 7.8％と推定されます。

米国市場は3億4,320万米ドルと推定、中国はCAGR11.9％で成長予測

米国の生物学的データの可視化市場は、2024年には3億4,320万米ドルと推定されます。世界第2位の経済大国である中国は、2024年から2030年の分析期間においてCAGR 11.9%で推移し、2030年には5億3,660万米ドルの市場規模に達すると予測されています。その他の注目すべき地域別市場としては、日本とカナダがあり、分析期間中のCAGRはそれぞれ3.4%と6.7%と予測されています。欧州では、ドイツがCAGR 4.3%で成長すると予測されています。

世界の生物学的データの可視化市場- 主要動向と促進要因まとめ

技術革新は生物学的データの可視化をどう変えるか？

データ分析および可視化ツールの技術的進歩が生物学的データの可視化市場に革命をもたらし、研究者は複雑なデータセットをより正確かつ迅速に解釈できるようになっています。生物学的データの可視化は、遺伝子配列、タンパク質構造、分子間相互作用などの生物学的データをグラフィカルに表現することで、生物学的プロセスや疾病メカニズムの理解を深めます。ビッグデータ解析、人工知能（AI）、機械学習（ML）における最近の技術革新は、大量の生物学的データを処理し、意味のある視覚的洞察を生み出す能力を向上させています。ハイパフォーマンスコンピューティング（HPC）プラットフォームとクラウドベースの可視化ツールは、生物学的データ解析のアクセシビリティとスケーラビリティをさらに向上させ、研究者が世界のプロジェクトにリアルタイムで協力できるようになっています。データ可視化ソフトウェアにAI駆動型アルゴリズムが統合されたことで、自動パターン認識と予測モデリングが可能になり、研究者は重要な生物学的動向や関係をより迅速に特定できるようになりました。このような進歩により、科学者の生物学的データの分析方法が変化し、より正確で効率的な創薬、ゲノム研究、個別化医療への取り組みが促進されています。

なぜ生物学的データの可視化がライフサイエンスに不可欠になったのか？

生物学的データの可視化は、最新の研究技術によって生成されるデータの量と複雑さが指数関数的に増加しているライフサイエンスにおいて、ますます必要不可欠になってきています。ゲノミクス、プロテオミクス、メタボロミクス研究や創薬研究では膨大な量のデータが生成されますが、意味のある洞察を明らかにするためには高度な可視化技術が必要です。複雑な生物学的データをグラフィカルなフォーマットで表現することで、研究者は可視化ツールによって、生データだけでは検出が困難なパターン、関係、異常を特定することができます。これは、遺伝子配列のマッピングや比較に視覚的ツールが使用されるゲノミクスや、タンパク質の構造や相互作用を視覚化できるプロテオミクスにおいて特に重要です。さらに、生物学的データの可視化は個別化医療の開発においても重要な役割を果たしています。そこでは、個々の遺伝子プロファイルに合わせた治療を行うために、患者固有のデータを分析する必要があります。ライフサイエンス分野の進歩に伴い、生物学的データの可視化は新たな発見を引き出し、科学の進歩を加速させるために不可欠なものとなっています。

業界とヘルスケアの動向は、生物学的データの可視化市場をどのように形成していますか？

生物学的データの可視化市場は、ヘルスケアおよびライフサイエンス業界におけるいくつかの主要動向、特に個別化医療への注目の高まりとマルチオミクス研究の台頭によって形成されています。個別化医療が普及し続けるにつれ、洗練されたデータ可視化ツールの必要性が顕著になってきています。研究開発者や臨床医は、ゲノム配列、プロテオミクスプロファイル、臨床記録などの大規模で複雑なデータセットを解析し、固有のバイオマーカーを特定し、個々の患者に合わせた治療法を開発する必要があります。このようなデータ駆動型の個別化ヘルスケアへのシフトは、患者固有のデータを扱い、解釈できる高度な生物学的データの可視化ソリューションへの需要を促進しています。さらに、ゲノミクス、プロテオミクス、トランスクリプトミクス、メタボロミクスなどのデータを統合するマルチオミクスアプローチの採用が拡大しており、生物学的データ解析の複雑性がさらに増しています。このような多層的なデータセットを首尾一貫した解釈可能な方法で統合・表示できる可視化ツールは、研究の進展と臨床転帰の改善に不可欠となっています。

生物学的データの可視化市場の成長を促進する要因とは？

生物学的データの可視化市場の成長は、生物学的研究の複雑化、データ分析の技術的進歩、個別化医療の役割の拡大など、いくつかの要因によってもたらされます。主な要因の1つは、ゲノムおよびマルチオミクス研究の急成長であり、分析に高度な可視化ツールを必要とする膨大な量のデータが生成されます。AIと機械学習の台頭も市場成長に寄与しています。これらの技術はデータ分析とパターン認識の自動化を可能にし、研究者が複雑な生物学的データから洞察を導き出すことを容易にするからです。さらに、個別化医療への注目の高まりは、臨床医が患者固有のデータを解釈し、オーダーメイドの治療計画を立てるのに役立つ可視化ツールの需要を促進しています。クラウドコンピューティングとハイパフォーマンスコンピューティングプラットフォームの拡大により、生物学的データの可視化ソリューションのアクセシビリティとスケーラビリティがさらに向上し、研究者が大規模なプロジェクトで共同作業を行い、世界規模で知見を共有できるようになっています。データ主導の調査と個別化ヘルスケアの需要が高まり続ける中、生物学的データの可視化市場は持続的な成長が見込まれています。

セグメント

技術（シーケンス、顕微鏡、磁気共鳴イメージング、X線結晶構造解析、その他の技術）、用途（細胞・生物イメージング、構造生物学・分子モデリング、ゲノム解析、アラインメント、系統・進化、システム生物学）、最終用途（学術研究、製薬・バイオテクノロジー企業、病院・クリニック、その他の最終用途）

調査対象企業の例

• 3M
• Advanced Visual Systems, Inc.
• Agilent Technologies
• arivis AG
• Becton, Dickinson and Company（BD）
• Carl Zeiss AG
• Clarivate Analytics
• Danaher
• Genedata AG
• Genialis, Inc.

AIインテグレーション

Global Industry Analystsは、有効な専門家コンテンツとAIツールによって、市場情報と競合情報を変革しています。

Global Industry Analystsは、一般的なLLMや業界別SLMのクエリに従う代わりに、ビデオ記録、ブログ、検索エンジン調査、大量の企業、製品/サービス、市場データなど、世界中の専門家から収集したコンテンツのリポジトリを構築しました。

関税影響係数

Global Industry Analystsは、本社の国、製造拠点、輸出入（完成品とOEM）に基づく企業の競争力の変化を予測しています。この複雑で多面的な市場力学は、売上原価（COGS）の増加、収益性の低下、サプライチェーンの再構築など、ミクロおよびマクロの市場力学の中でも特に競合他社に影響を与える見込みです。

目次

第1章 調査手法

第2章 エグゼクティブサマリー

• 市場概要
• 主要企業
• 市場動向と促進要因
• 世界市場の見通し

第3章 市場分析

• 米国
• カナダ
• 日本
• 中国
• 欧州
• フランス
• ドイツ
• イタリア
• 英国
• スペイン
• ロシア
• その他欧州
• アジア太平洋
• オーストラリア
• インド
• 韓国
• その他アジア太平洋地域
• ラテンアメリカ
• アルゼンチン
• ブラジル
• メキシコ
• その他ラテンアメリカ
• 中東
• イラン
• イスラエル
• サウジアラビア
• アラブ首長国連邦
• その他中東
• アフリカ

第4章 競合

Global Biological Data Visualization Market to Reach US$2.1 Billion by 2030

The global market for Biological Data Visualization estimated at US$1.3 Billion in the year 2024, is expected to reach US$2.1 Billion by 2030, growing at a CAGR of 7.8% over the analysis period 2024-2030. Sequencing, one of the segments analyzed in the report, is expected to record a 7.9% CAGR and reach US$814.5 Million by the end of the analysis period. Growth in the Microscopy segment is estimated at 7.8% CAGR over the analysis period.

The U.S. Market is Estimated at US$343.2 Million While China is Forecast to Grow at 11.9% CAGR

The Biological Data Visualization market in the U.S. is estimated at US$343.2 Million in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$536.6 Million by the year 2030 trailing a CAGR of 11.9% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 3.4% and 6.7% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 4.3% CAGR.

Global Biological Data Visualization Market - Key Trends & Drivers Summarized

How Are Technological Innovations Transforming Biological Data Visualization?

Technological advancements in data analytics and visualization tools are revolutionizing the biological data visualization market, enabling researchers to interpret complex datasets with greater precision and speed. Biological data visualization involves the graphical representation of biological data, such as genetic sequences, protein structures, and molecular interactions, to enhance the understanding of biological processes and disease mechanisms. Recent innovations in big data analytics, artificial intelligence (AI), and machine learning (ML) are improving the ability to process large volumes of biological data and generate meaningful visual insights. High-performance computing (HPC) platforms and cloud-based visualization tools are further enhancing the accessibility and scalability of biological data analysis, allowing researchers to collaborate on global projects in real time. The integration of AI-driven algorithms in data visualization software is enabling automated pattern recognition and predictive modeling, helping researchers identify critical biological trends and relationships faster. These advancements are transforming the way scientists analyze biological data, facilitating more accurate and efficient drug discovery, genomics research, and personalized medicine initiatives.

Why Is Biological Data Visualization Becoming Essential in Life Sciences?

Biological data visualization is becoming increasingly essential in the life sciences, where the volume and complexity of data generated by modern research techniques are growing exponentially. Genomics, proteomics, and metabolomics research, as well as drug discovery, generate vast amounts of data that require sophisticated visualization techniques to uncover meaningful insights. By representing complex biological data in a graphical format, visualization tools enable researchers to identify patterns, relationships, and anomalies that would be difficult to detect through raw data alone. This is particularly important in genomics, where visual tools are used to map and compare genetic sequences, and in proteomics, where researchers can visualize protein structures and interactions. Additionally, biological data visualization is playing a critical role in the development of personalized medicine, where patient-specific data must be analyzed to tailor treatments to individual genetic profiles. As the life sciences field continues to advance, biological data visualization is becoming indispensable for unlocking new discoveries and accelerating scientific progress.

How Are Industry and Healthcare Trends Shaping the Biological Data Visualization Market?

The biological data visualization market is being shaped by several key trends in the healthcare and life sciences industries, particularly the increasing focus on personalized medicine and the rise of multi-omics research. As personalized medicine continues to gain traction, the need for sophisticated data visualization tools is becoming more pronounced. Researchers and clinicians must analyze large, complex datasets-such as genomic sequences, proteomic profiles, and clinical records-to identify unique biomarkers and develop tailored therapies for individual patients. This shift toward data-driven, personalized healthcare is driving demand for advanced biological data visualization solutions that can handle and interpret patient-specific data. Moreover, the growing adoption of multi-omics approaches, which integrate data from genomics, proteomics, transcriptomics, and metabolomics, is further increasing the complexity of biological data analysis. Visualization tools that can synthesize and display these multi-layered datasets in a coherent and interpretable manner are becoming critical for advancing research and improving clinical outcomes.

What Factors Are Driving Growth in the Biological Data Visualization Market?

The growth in the biological data visualization market is driven by several factors, including the increasing complexity of biological research, technological advancements in data analytics, and the expanding role of personalized medicine. One of the primary drivers is the rapid growth of genomics and multi-omics research, which generates vast amounts of data that require sophisticated visualization tools to analyze. The rise of AI and machine learning is also contributing to market growth, as these technologies enable the automation of data analysis and pattern recognition, making it easier for researchers to derive insights from complex biological data. Additionally, the growing focus on personalized medicine is driving demand for visualization tools that can help clinicians interpret patient-specific data and develop tailored treatment plans. The expansion of cloud computing and high-performance computing platforms is further enhancing the accessibility and scalability of biological data visualization solutions, enabling researchers to collaborate on large-scale projects and share insights globally. As the demand for data-driven research and personalized healthcare continues to rise, the biological data visualization market is expected to experience sustained growth.

SCOPE OF STUDY:

The report analyzes the Biological Data Visualization market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Technique (Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography, Other Techniques); Application (Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis, Alignments, Phylogeny & Evolution, Systems Biology); End-Use (Academic Research, Pharma & Biotech Companies, Hospitals & Clinics, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 33 Featured) -

• 3M
• Advanced Visual Systems, Inc.
• Agilent Technologies
• arivis AG
• Becton, Dickinson and Company (BD)
• Carl Zeiss AG
• Clarivate Analytics
• Danaher
• Genedata AG
• Genialis, Inc.

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

• 1. MARKET OVERVIEW
  • Influencer Market Insights
  • Tariff Impact on Global Supply Chain Patterns
  • Global Economic Update
  • Biological Data Visualization - Global Key Competitors Percentage Market Share in 2025 (E)
  • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
• 2. FOCUS ON SELECT PLAYERS
• 3. MARKET TRENDS & DRIVERS
  • Rising Volume of Genomic and Proteomic Data Drives Growth in the Biological Data Visualization Market
  • Technological Advancements in Data Analytics Propel the Use of Visualization Tools in Life Sciences
  • Increasing Adoption of Big Data in Healthcare and Biotechnology Expands Market for Biological Data Visualization
  • Growing Focus on Precision Medicine Fuels Demand for Advanced Visualization Tools in Genomic Research
  • Technological Innovations in 3D and Virtual Reality (VR) Visualization Enhance Interpretation of Complex Biological Data
  • Rising Use of Artificial Intelligence (AI) and Machine Learning (ML) in Biological Data Visualization Expands Capabilities
  • Growing Integration of Cloud Computing and Visualization Software Strengthens Market for Real-Time Data Analysis
  • Increased Adoption of Biological Data Visualization Tools in Drug Discovery and Development Expands Market Scope
  • Technological Developments in Multi-Omics Data Integration Drive Demand for Advanced Visualization Platforms
  • Rising Focus on Collaborative Research and Data Sharing Expands Use of Cloud-Based Visualization Tools in Life Sciences
  • Growing Use of Biological Data Visualization in Clinical Research and Trials Expands Opportunities for Personalized Medicine
  • Increased Adoption of Biological Data Visualization in Agricultural Genomics and Crop Improvement Expands Market
  • Technological Integration of Augmented Reality (AR) with Biological Data Visualization Tools Enhances Research Insights
• 4. GLOBAL MARKET PERSPECTIVE
  • TABLE 1: World Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 2: World Historic Review for Biological Data Visualization by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 3: World 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
  • TABLE 4: World Recent Past, Current & Future Analysis for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 5: World Historic Review for Sequencing by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 6: World 15-Year Perspective for Sequencing by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 7: World Recent Past, Current & Future Analysis for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 8: World Historic Review for Microscopy by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 9: World 15-Year Perspective for Microscopy by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 10: World Recent Past, Current & Future Analysis for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 11: World Historic Review for Magnetic Resonance Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 12: World 15-Year Perspective for Magnetic Resonance Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 13: World Recent Past, Current & Future Analysis for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 14: World Historic Review for X-ray Crystallography by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 15: World 15-Year Perspective for X-ray Crystallography by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 16: World Recent Past, Current & Future Analysis for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 17: World Historic Review for Other Techniques by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 18: World 15-Year Perspective for Other Techniques by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 19: World Recent Past, Current & Future Analysis for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 20: World Historic Review for Systems Biology by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 21: World 15-Year Perspective for Systems Biology by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 22: World Recent Past, Current & Future Analysis for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 23: World Historic Review for Cell & Organism Imaging by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 24: World 15-Year Perspective for Cell & Organism Imaging by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 25: World Recent Past, Current & Future Analysis for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 26: World Historic Review for Structural Biology & Molecular Modeling by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 27: World 15-Year Perspective for Structural Biology & Molecular Modeling by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 28: World Recent Past, Current & Future Analysis for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 29: World Historic Review for Genomic Analysis by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 30: World 15-Year Perspective for Genomic Analysis by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 31: World Recent Past, Current & Future Analysis for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 32: World Historic Review for Alignments, Phylogeny & Evolution by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 33: World 15-Year Perspective for Alignments, Phylogeny & Evolution by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 34: World Recent Past, Current & Future Analysis for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 35: World Historic Review for Academic Research by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 36: World 15-Year Perspective for Academic Research by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 37: World Recent Past, Current & Future Analysis for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 38: World Historic Review for Pharma & Biotech Companies by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 39: World 15-Year Perspective for Pharma & Biotech Companies by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 40: World Recent Past, Current & Future Analysis for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 41: World Historic Review for Hospitals & Clinics by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 42: World 15-Year Perspective for Hospitals & Clinics by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 43: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 44: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 45: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
  • TABLE 46: World Biological Data Visualization Market Analysis of Annual Sales in US$ Thousand for Years 2015 through 2030

III. MARKET ANALYSIS

• UNITED STATES
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
  • TABLE 47: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 48: USA Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 49: USA 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 50: USA Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 51: USA Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 52: USA 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 53: USA Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 54: USA Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 55: USA 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CANADA
  • TABLE 56: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 57: Canada Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 58: Canada 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 59: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 60: Canada Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 61: Canada 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 62: Canada Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 63: Canada Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 64: Canada 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• JAPAN
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
  • TABLE 65: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 66: Japan Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 67: Japan 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 68: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 69: Japan Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 70: Japan 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 71: Japan Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 72: Japan Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 73: Japan 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• CHINA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
  • TABLE 74: China Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 75: China Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 76: China 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 77: China Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 78: China Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 79: China 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 80: China Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 81: China Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 82: China 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• EUROPE
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
  • TABLE 83: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 84: Europe Historic Review for Biological Data Visualization by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 85: Europe 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
  • TABLE 86: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 87: Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 88: Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 89: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 90: Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 91: Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 92: Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 93: Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 94: Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• FRANCE
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
  • TABLE 95: France Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 96: France Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 97: France 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 98: France Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 99: France Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 100: France 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 101: France Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 102: France Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 103: France 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• GERMANY
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
  • TABLE 104: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 105: Germany Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 106: Germany 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 107: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 108: Germany Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 109: Germany 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 110: Germany Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 111: Germany Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 112: Germany 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ITALY
  • TABLE 113: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 114: Italy Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 115: Italy 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 116: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 117: Italy Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 118: Italy 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 119: Italy Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 120: Italy Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 121: Italy 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED KINGDOM
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
  • TABLE 122: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 123: UK Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 124: UK 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 125: UK Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 126: UK Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 127: UK 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 128: UK Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 129: UK Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 130: UK 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SPAIN
  • TABLE 131: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 132: Spain Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 133: Spain 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 134: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 135: Spain Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 136: Spain 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 137: Spain Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 138: Spain Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 139: Spain 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• RUSSIA
  • TABLE 140: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 141: Russia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 142: Russia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 143: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 144: Russia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 145: Russia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 146: Russia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 147: Russia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 148: Russia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF EUROPE
  • TABLE 149: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 150: Rest of Europe Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 151: Rest of Europe 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 152: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 153: Rest of Europe Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 154: Rest of Europe 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 155: Rest of Europe Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 156: Rest of Europe Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 157: Rest of Europe 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ASIA-PACIFIC
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
  • TABLE 158: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 159: Asia-Pacific Historic Review for Biological Data Visualization by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 160: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
  • TABLE 161: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 162: Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 163: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 164: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 165: Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 166: Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 167: Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 168: Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 169: Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AUSTRALIA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
  • TABLE 170: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 171: Australia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 172: Australia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 173: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 174: Australia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 175: Australia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 176: Australia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 177: Australia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 178: Australia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• INDIA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
  • TABLE 179: India Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 180: India Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 181: India 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 182: India Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 183: India Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 184: India 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 185: India Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 186: India Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 187: India 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SOUTH KOREA
  • TABLE 188: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 189: South Korea Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 190: South Korea 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 191: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 192: South Korea Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 193: South Korea 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 194: South Korea Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 195: South Korea Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 196: South Korea 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF ASIA-PACIFIC
  • TABLE 197: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 198: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 199: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 200: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 201: Rest of Asia-Pacific Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 202: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 203: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 204: Rest of Asia-Pacific Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 205: Rest of Asia-Pacific 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• LATIN AMERICA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
  • TABLE 206: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 207: Latin America Historic Review for Biological Data Visualization by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 208: Latin America 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
  • TABLE 209: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 210: Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 211: Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 212: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 213: Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 214: Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 215: Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 216: Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 217: Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ARGENTINA
  • TABLE 218: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 219: Argentina Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 220: Argentina 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 221: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 222: Argentina Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 223: Argentina 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 224: Argentina Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 225: Argentina Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 226: Argentina 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• BRAZIL
  • TABLE 227: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 228: Brazil Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 229: Brazil 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 230: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 231: Brazil Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 232: Brazil 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 233: Brazil Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 234: Brazil Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 235: Brazil 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MEXICO
  • TABLE 236: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 237: Mexico Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 238: Mexico 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 239: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 240: Mexico Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 241: Mexico 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 242: Mexico Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 243: Mexico Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 244: Mexico 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF LATIN AMERICA
  • TABLE 245: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 246: Rest of Latin America Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 247: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 248: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 249: Rest of Latin America Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 250: Rest of Latin America 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 251: Rest of Latin America Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 252: Rest of Latin America Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 253: Rest of Latin America 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• MIDDLE EAST
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
  • TABLE 254: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2024 through 2030 and % CAGR
  • TABLE 255: Middle East Historic Review for Biological Data Visualization by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 256: Middle East 15-Year Perspective for Biological Data Visualization by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
  • TABLE 257: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 258: Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 259: Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 260: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 261: Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 262: Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 263: Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 264: Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 265: Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• IRAN
  • TABLE 266: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 267: Iran Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 268: Iran 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 269: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 270: Iran Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 271: Iran 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 272: Iran Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 273: Iran Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 274: Iran 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• ISRAEL
  • TABLE 275: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 276: Israel Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 277: Israel 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 278: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 279: Israel Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 280: Israel 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 281: Israel Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 282: Israel Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 283: Israel 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• SAUDI ARABIA
  • TABLE 284: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 285: Saudi Arabia Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 286: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 287: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 288: Saudi Arabia Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 289: Saudi Arabia 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 290: Saudi Arabia Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 291: Saudi Arabia Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 292: Saudi Arabia 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• UNITED ARAB EMIRATES
  • TABLE 293: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 294: UAE Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 295: UAE 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 296: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 297: UAE Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 298: UAE 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 299: UAE Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 300: UAE Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 301: UAE 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• REST OF MIDDLE EAST
  • TABLE 302: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 303: Rest of Middle East Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 304: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 305: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 306: Rest of Middle East Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 307: Rest of Middle East 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 308: Rest of Middle East Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 309: Rest of Middle East Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 310: Rest of Middle East 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030
• AFRICA
  • Biological Data Visualization Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
  • TABLE 311: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 312: Africa Historic Review for Biological Data Visualization by Technique - Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 313: Africa 15-Year Perspective for Biological Data Visualization by Technique - Percentage Breakdown of Value Sales for Sequencing, Microscopy, Magnetic Resonance Imaging, X-ray Crystallography and Other Techniques for the Years 2015, 2025 & 2030
  • TABLE 314: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 315: Africa Historic Review for Biological Data Visualization by Application - Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 316: Africa 15-Year Perspective for Biological Data Visualization by Application - Percentage Breakdown of Value Sales for Systems Biology, Cell & Organism Imaging, Structural Biology & Molecular Modeling, Genomic Analysis and Alignments, Phylogeny & Evolution for the Years 2015, 2025 & 2030
  • TABLE 317: Africa Recent Past, Current & Future Analysis for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses - Independent Analysis of Annual Sales in US$ Thousand for the Years 2024 through 2030 and % CAGR
  • TABLE 318: Africa Historic Review for Biological Data Visualization by End-Use - Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Thousand for Years 2015 through 2023 and % CAGR
  • TABLE 319: Africa 15-Year Perspective for Biological Data Visualization by End-Use - Percentage Breakdown of Value Sales for Academic Research, Pharma & Biotech Companies, Hospitals & Clinics and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION